Searchable abstracts of presentations at key conferences in endocrinology

ea0016p215 | Diabetes and cardiovascular diseases | ECE2008

Metabolic changes induced by glucose infusion in persons with Glu23Lys polymorphism

Bobbert Thomas , Mittag Marc , Mai Knut , Fischer Antje , Arafat Ayman , Pfeiffer AFH , Spranger Joachim

The development of diabetes mellitus type 2 (T2DM) is affected by genetic and lifestyle factors. Polymorphisms within the KIR6.2 gene seem to be associated with a higher risk for T2DM. The protein encoded by this gene represents a potassium channel, which plays an essential role in insulin and glucagon secretion by the pancreas.A hyperglycaemic clamp without insulin was performed over 2 h in 10 healthy persons with the Kir6.2 E23K wild type Glu/Glu, 10 a...

ea0016p217 | Diabetes and cardiovascular diseases | ECE2008

GC-tofMS metabolite profiling in the pancreatic beta cell line INS-1 under chronic glucose stress conditions

Gohring Isabel , Catchpole Gareth , Eckardt Anne , Willmitzer Lothar , Pfeiffer Andreas FH , Spranger Joachim

Background: Long term exposure of INS-1 beta cells to elevated glucose concentrations has been observed to impair insulin expression, a phenomenon termed as glucose toxicity. Despite its potential relevance in the progression of diabetes, the underlying mechanisms is not yet fully understood.Aim: Target analysis of single, or a sub-group of metabolites has until now been the method of choice in mammalian cells to investigate the pathological state in ter...

ea0016p543 | Obesity | ECE2008

Glucose-dependent insulinotropic polypeptide (GIP) modulates inflammatory markers and regulates cell proliferation in subcutaneous adipose tissue

Gogebakan Ozlem , Mosig Sandy , Middelbeck Ines , Osterhoff Martin A , Isken Frank , Rudovich Natalia , Pfeiffer Andreas F H

Background: Glucose-dependent insulinotropic polypeptide (GIP) is a gastrointestinal hormone that is secreted in response to food intake and modulates β-cell function. Remarkably, GIP looses its insulinomimetic effect in the presence of chronic hyperglycaemia and thus appears to be ineffective in poorly controlled T2DM at least with regard to insulin release. The mechanism by which this occurs is not clear and it is not known.Objectives: To analyse ...

ea0081oc10.2 | Oral Communications 10: Diabetes, Obesity, Metabolism and Nutrition 3 | ECE2022

Success in implementing changes in macronutrients intake in a high-protein and high-unsaturated fatty acids dietary intervention: 36-months results of the NutriAct randomized controlled multi-center trial

Pletsch-Borba Laura , Wernicke Charlotte , Meyer Nina , Nguyen Thu , Pohrt Anne , Gerbracht Christiana , Pfeiffer Andreas , Spranger Joachim , Mai Knut

Background & Aims: NutriAct is a 36-month randomized controlled multi-center trial aiming to analyze the effects of a dietary pattern focusing on a high-protein and high-unsaturated fatty acids (UFA) intake on healthy aging. We aimed to explore changes in intake of macronutrients and determine factors associated with a successful modulation of dietary pattern after 36 months in elderly community dwelling participants.Methods: 502 participants were ra...

ea0026p232 | Pituitary | ECE2011

Copeptin in the differential diagnosis of the polydipsia–polyuria syndrome: revisiting the direct and indirect water deprivation tests

Fenske W K , Quinkler M , Haagen U , Papassotiriou J , Pfeiffer A F H , Fassnacht M , Stoerk S , Allolio B

Background: The water deprivation test (WDT) with direct or indirect measurement of plasma vasopressin (AVP) is the method of choice for the differential diagnosis of the polydipsia–polyuria syndrome. In theory, direct measurement of AVP is highly attractive but hampered by technical difficulties.Objective: To evaluate the utility of copeptin, a surrogate of AVP secretion, in the diagnostic work-up of the polyuria–polydipsia syndrome, and to co...

ea0022p713 | Obesity | ECE2010

Gastric inhibitory polypeptide (GIP) suppresses circulating ghrelin in humans: plasma metabolome based correlation network analysis for support of hormone-to- hormone interactions

Rudovich Natalia , Nikiforova Victoria J , Otto Baerbel , Pivovarova Olga , Gogebakan Ozlem , Weickert Martin O , Nauck Michael A , Pfeiffer Andreas F H

Aims: We investigate the influence of GIP on ghrelin secretion in normal glucose tolerant individuals with the use of the firstly applied correlation network analysis on human plasma metabolome data.Methods: To address this issue, we employed a GIP-infusion test and euglycemic- and hyperglycemic glucose clamp experiments combined with infusion of GIP or placebo in a cross-over manner in non diabetic obese male subjects (n=14). Moreover, we firstly...

ea0016p515 | Obesity | ECE2008

Glucose-dependent insulinotropic polypeptide (GIP) receptor knock-out prevents ovariectomy-induced obesity in mice

Isken Frank , Pfeiffer Andreas FH , Nogueiras Ruben , Osterhoff Martin A , Ristow Michael , Thorens Bernard , Tschop Matthias H , Weickert Martin O

Objectives: Premature estrogen deficiency and menopause are associated with increases in body weight and fat mass. Ovariectomized (OVX) mice also show reduced locomotor activity. Because glucose-dependent-insulinotropic-polypeptide (GIP) is known to play an important role both in fat metabolism and locomotor activity, we hypothesized that effects of estrogen on the regulation of body weight, fat mass and spontaneous physical activity could be mediated in part by GIP signaling....

ea0016p540 | Obesity | ECE2008

Retinol-binding protein 4 is independently associated with insulin resistance in PCOS women

Mohlig Matthias , Weickert Martin O , Ghadamgahi Elham , Arafat Ayman M , Spranger Joachim , Pfeiffer Andreas FH , Schofl Christof

Objective: Adiposity, insulin resistance, and hyperandrogenism are features of the polycystic ovary syndrome (PCOS). Retinol-binding protein 4 (RBP4) secreted from adipose and liver tissue has been linked to insulin resistance. We here address the impact of RBP4 on insulin resistance in PCOS and its usability to identify women with metabolic syndrome or impaired glucose metabolism (IGT or diabetes).Design: RBP4 was determined in plasma of 115 PCOS...

ea0037gp.17.03 | Pituitary–Neuroendocrinology and central salt regulation | ECE2015

Insulin-induced hypoglycaemia decreases IGF1 bioactivity in humans: a missing link to increased mortality in diabetic patients?

Sarem Zeinab , Assefa Biruhalem , Weickert Martin O , Adamidou Aikatarini , Frystyk Jan , Mohlig Matthias , Lieske Stefanie , Birkenfeld Andreas L , Pfeiffer A.F.H , Spranger Joachim , Arafat Ayman M

Background: The mechanisms underlying the association between severe hypoglycaemia and increased cardiovascular mortality among patients with diabetes mellitus are not fully understood. Our aim was to evaluate changes in GH/IGF1 axis during insulin-induced hypoglycaemia, as a possible link.Methods: Twenty-five healthy subjects, 12 obese participants (OP; 6/ 6; 34.4±1.7 kg/m2), and 13 healthy lean participants (LP; 6/ 7; 21.7±0.6 kg/m...

ea0070aep283 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Identification of a diagnostic and prognostic miRNA signature in women with gestational diabetes mellitus

Sanchez-Lechuga Begoña , Pfeiffer Shonna , Halang Luise , Prehn Jochen HM , Campos-Caro Antonio , Byrne Maria M , López-Tinoco Cristina

Gestational Diabetes Mellitus (GDM) is characterized by insulin resistance accompanied byreduced beta-cell compensation to increased insulin demand, typically observed in the secondand third trimester and associated with adverse pregnancy outcomes. There is a need for abiomarker that can accurately diagnose GDM, predict onset and accurately monitor status, reducing foetal-maternal morbidity and mortality risks. To this end, circulating microRNAs(miRNAs) present themselves as p...